Stay updated on Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page.

Latest updates to the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe update shows a revision from v3.4.1 to v3.4.2 with no substantive changes to the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page revision updated from v3.4.0 to v3.4.1; no study data, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a Show glossary option and updated administrative labels to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the former wording 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page adds a Locations section with Jiangsu listed as a site and updates the Jiangsu location entry; the HHS Vulnerability Disclosure link is removed and the revision note updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedMinor editorial updates: the PubMed publications note now clarifies that these items are automatically filled from PubMed, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of Quadrivalent Influenza Vaccine Clinical Trial page.